Progeria interventions: Difference between revisions
Created page with "__NOTOC__ {{Xyz}} {{CMG}}; ==Overview== There are no recommended therapeutic interventions for the management of [disease name]. OR [Name of intervention] is not the first..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Progeria}} | ||
{{CMG}}; | {{CMG}}; {{AE}} {{VKG}} | ||
==Overview== | ==Overview== | ||
| Line 31: | Line 31: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Rare disease]] | ||
Revision as of 02:14, 14 August 2019
|
Progeria Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Progeria interventions On the Web |
|
American Roentgen Ray Society Images of Progeria interventions |
|
Risk calculators and risk factors for Progeria interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
There are no recommended therapeutic interventions for the management of [disease name].
OR
[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
OR
[Name of intervention] is the mainstay of treatment for [disease or malignancy].
Indications
The mainstay of treatment for TT is medical therapy.